Your monthly shot of news from Children's Hospital Boston
Formerly Children's Outlook
 
September 2008

 

Normalizing tumor vessels could improve chemotherapy
Donald Ingber, MD, PhD, and fellow Vascular Biology Center researchers now have an explanation for the abnormality of a tumor’s blood vessels, an insight that could improve chemotherapy drug delivery.

Rare but serious complications of acne drug
Minocycline has potential for occasionally inducing serious autoimmune phenomena.

Motor neurons implicated in eye movement disorder
Elizabeth Engle, MD, and colleagues have identified a gene mutated in Duane syndrome, a disorder affecting 1 in 1,000 people that restricts the movement of the eyes.

Enhanced genetic profiling of cancers
Researchers at Children’s Informatics Program (CHIP) show how cancers can be divided into three distinct groups, offering new insight into patient prognoses and optimal treatment plans.

Predicting the severity of sickle cell disease
Scientists at Children’s, Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard report five gene variants that could help predict sickle cell disease severity.

LIVE WEBCAST
Robotically-Assisted
Ureteral Reimplantation

9/16, 2:00 p.m. EDT

CHB Alumni Cocktail Reception
and Hospital Tour

10/11 and 10/12
Boston, MA

Advances in Pediatric Health Care
11/05, 7:30 a.m. to 3:45 p.m.
Norwood, MA

Pediatric Plastic Surgery Symposium
2/20/09 in San Juan,
Puerto Rico

  CME Calendar
  Careers
  News at Children's
  Research
  Find a Clinical Trial *NEW*   Find a Specialist
  Request an Appointment
  How to Refer a Patient
  Contact Us